MYO3A

myosin IIIA, the group of Myosin heavy chains, class III

Basic information

Region (hg38): 10:25934229-26212532

Previous symbols: [ "DFNB30" ]

Links

ENSG00000095777NCBI:53904OMIM:606808HGNC:7601Uniprot:Q8NEV4AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • autosomal recessive nonsyndromic hearing loss 30 (Strong), mode of inheritance: AR
  • autosomal recessive nonsyndromic hearing loss 30 (Moderate), mode of inheritance: Semidominant
  • hearing loss, autosomal recessive (Supportive), mode of inheritance: AR
  • autosomal recessive nonsyndromic hearing loss 30 (Strong), mode of inheritance: AR
  • nonsyndromic genetic hearing loss (Definitive), mode of inheritance: AR
  • autosomal recessive nonsyndromic hearing loss 30 (Definitive), mode of inheritance: AR
  • hearing loss, autosomal dominant 90 (Moderate), mode of inheritance: AD

Clinical Genomic Database

Source: CGD

ConditionInheritanceIntervention CategoriesIntervention/Rationale Manifestation CategoriesReferences
Deafness, autosomal dominant 90; Deafness, autosomal recessive 30AD/ARAudiologic/OtolaryngologicEarly recognition and treatment of hearing impairment may improve outcomes, including speech and language developmentAudiologic/Otolaryngologic12032315; 29880844; 32519820

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the MYO3A gene.

  • not provided (20 variants)
  • Autosomal recessive nonsyndromic hearing loss 30 (7 variants)
  • Nonsyndromic genetic hearing loss (1 variants)
  • MYO3A-related disorder (1 variants)
  • Sensorineural hearing loss disorder (1 variants)
  • nonsyndromic sensorineural hearing loss (1 variants)
  • Hearing loss, autosomal dominant 90 (1 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the MYO3A gene is commonly pathogenic or not. These statistics are base on transcript: . Only rare variants are included in the table.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
9
clinvar
74
clinvar
5
clinvar
88
missense
1
clinvar
296
clinvar
16
clinvar
7
clinvar
320
nonsense
10
clinvar
5
clinvar
7
clinvar
22
start loss
1
1
frameshift
11
clinvar
7
clinvar
3
clinvar
21
splice donor/acceptor (+/-2bp)
3
clinvar
15
clinvar
3
clinvar
21
Total 25 27 319 90 12

Highest pathogenic variant AF is 0.0000525742

Loading clinvar variants...

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
MYO3Aprotein_codingprotein_codingENST00000265944 33278261
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
1.81e-450.000037312536703811257480.00152
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense-0.1328418301.010.000042110659
Missense in Polyphen220232.940.944433042
Synonymous-0.9473102901.070.00001462936
Loss of Function1.237688.50.8590.000004681119

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.002480.00247
Ashkenazi Jewish0.0008930.000893
East Asian0.001250.00125
Finnish0.0002320.000139
European (Non-Finnish)0.001510.00149
Middle Eastern0.001250.00125
South Asian0.003110.00311
Other0.001470.00147

dbNSFP

Source: dbNSFP

Function
FUNCTION: Probable actin-based motor with a protein kinase activity. Probably plays a role in vision and hearing (PubMed:12032315). Required for normal cochlear hair bundle development and hearing. Plays an important role in the early steps of cochlear hair bundle morphogenesis. Influences the number and lengths of stereocilia to be produced and limits the growth of microvilli within the forming auditory hair bundles thereby contributing to the architecture of the hair bundle, including its staircase pattern. Involved in the elongation of actin in stereocilia tips by transporting the actin regulatory factor ESPN to the plus ends of actin filaments (By similarity). {ECO:0000250|UniProtKB:Q8K3H5, ECO:0000269|PubMed:12032315}.;

Recessive Scores

pRec
0.165

Intolerance Scores

loftool
0.265
rvis_EVS
1
rvis_percentile_EVS
90.66

Haploinsufficiency Scores

pHI
0.165
hipred
N
hipred_score
0.299
ghis

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
E
gene_indispensability_score
0.831

Gene Damage Prediction

AllRecessiveDominant
MendelianHighHighHigh
Primary ImmunodeficiencyHighHighHigh
CancerHighHighHigh

Mouse Genome Informatics

Gene name
Myo3a
Phenotype
behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); hearing/vestibular/ear phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan);

Gene ontology

Biological process
visual perception;sensory perception of sound;protein autophosphorylation;response to stimulus;cochlea morphogenesis
Cellular component
cytoplasm;myosin complex;filopodium;filamentous actin;stereocilium tip;filopodium tip
Molecular function
microfilament motor activity;actin binding;protein kinase activity;protein serine/threonine kinase activity;protein binding;calmodulin binding;ATP binding;actin-dependent ATPase activity;ADP binding;plus-end directed microfilament motor activity